NO965381L - Pellets - Google Patents

Pellets

Info

Publication number
NO965381L
NO965381L NO965381A NO965381A NO965381L NO 965381 L NO965381 L NO 965381L NO 965381 A NO965381 A NO 965381A NO 965381 A NO965381 A NO 965381A NO 965381 L NO965381 L NO 965381L
Authority
NO
Norway
Prior art keywords
cores
pharmaceutical
preparation
coating
pellets
Prior art date
Application number
NO965381A
Other languages
English (en)
Other versions
NO315544B1 (no
NO965381D0 (no
Inventor
Thomas Norling
Lone Noergaard Jensen
Jens Hansen
Original Assignee
Dumex Ltd As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dumex Ltd As filed Critical Dumex Ltd As
Publication of NO965381D0 publication Critical patent/NO965381D0/no
Publication of NO965381L publication Critical patent/NO965381L/no
Publication of NO315544B1 publication Critical patent/NO315544B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Medicinal Preparation (AREA)
NO19965381A 1994-06-15 1996-12-13 Farmasöytisk preparat samt fremstilling derav NO315544B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK69594 1994-06-15
PCT/DK1995/000240 WO1995034291A1 (en) 1994-06-15 1995-06-14 Pellets

Publications (3)

Publication Number Publication Date
NO965381D0 NO965381D0 (no) 1996-12-13
NO965381L true NO965381L (no) 1997-02-13
NO315544B1 NO315544B1 (no) 2003-09-22

Family

ID=8096481

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19965381A NO315544B1 (no) 1994-06-15 1996-12-13 Farmasöytisk preparat samt fremstilling derav

Country Status (12)

Country Link
EP (1) EP0765157B1 (no)
AT (1) ATE177944T1 (no)
AU (1) AU697456B2 (no)
CA (1) CA2192086C (no)
DE (1) DE69508580T2 (no)
DK (1) DK0765157T3 (no)
ES (1) ES2131318T3 (no)
FI (1) FI118675B (no)
GR (1) GR3030256T3 (no)
NO (1) NO315544B1 (no)
NZ (1) NZ288185A (no)
WO (1) WO1995034291A1 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1011045A3 (fr) * 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
US6200604B1 (en) * 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US6350470B1 (en) 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
CA2241342C (en) * 1998-06-15 2000-02-08 Bernard Charles Sherman Pharmaceutical tablets comprising an nsaid and a prostaglandin
GB9819272D0 (en) * 1998-09-03 1998-10-28 Andaris Ltd Microparticles
GB0003782D0 (en) 2000-02-17 2000-04-05 Dumex Ltd As Process
AUPR272901A0 (en) * 2001-01-25 2001-02-22 Gainful Plan Limited Method of preparing biological materials and preparations produced using same
US20030068356A1 (en) 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems
ITMI20011632A1 (it) * 2001-07-27 2003-01-27 Sanofi Synthelabo Composizione solida contenente spore di batteri non patogeni del genere bacillus
DE10221726A1 (de) * 2002-05-16 2003-11-27 Sachtleben Chemie Gmbh Verwendung von Röntgenbaryt als Zusatz-und/oder Hilfsstoff bei der Herstellung von Arzneimitteln, Lebensmitteln und Kosmetika
US9107804B2 (en) 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
US7862833B2 (en) 2003-12-31 2011-01-04 Cima Labs, Inc. Effervescent oral opiate dosage forms and methods of administering opiates
EP1915137B8 (de) 2005-08-10 2013-09-11 ADD Advanced Drug Delivery Technologies, Ltd. Orales präparat mit kontrollierter freisetzung
EP1834634A3 (en) * 2006-03-08 2007-10-03 Rentschler Pharma GmbH Pharmaceutical multiple-unit composition
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
EP2598123A1 (en) * 2010-07-27 2013-06-05 Norgine BV Compositions
WO2012091040A1 (ja) * 2010-12-27 2012-07-05 富田製薬株式会社 製剤用崩壊型核粒子
US10405568B2 (en) * 2012-11-19 2019-09-10 Tracy L. Lundberg Flowable food composition with water-holding and lubricating agents
CN117049933B (zh) * 2023-08-11 2025-02-18 西北大学 一种可热塑成型的复合钨系延期药及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2292747A2 (fr) * 1973-09-14 1976-06-25 Gewerk Victor Chem Werke Procede de preparation de carbonate de calcium de grande finesse et de masse volumique elevee, aisement dispersable
US4096246A (en) * 1976-10-06 1978-06-20 A/S Apothekernes Laboratorium For Specialpraeparater Zinc bacitracin composition for use as a feed supplement and method for making the same
US4164572A (en) * 1976-10-06 1979-08-14 A/S Apothekernes Laboratorium For Specialpraeparater Zinc bacitracin composition for use as a feed supplement and method for making the same
JPS5823361B2 (ja) * 1976-10-26 1983-05-14 クミアイ化学工業株式会社 顆粒状農薬の製造法
SE450087B (sv) * 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
DE3900811A1 (de) * 1989-01-13 1990-07-19 Kali Chemie Pharma Gmbh Neue arzneiform
EP0452862B1 (en) * 1990-04-18 1995-07-19 Asahi Kasei Kogyo Kabushiki Kaisha Spherical seed cores, spherical granules and process for production thereof
JPH04283520A (ja) * 1991-03-12 1992-10-08 Asahi Chem Ind Co Ltd 球状核および球形顆粒

Also Published As

Publication number Publication date
AU697456B2 (en) 1998-10-08
EP0765157A1 (en) 1997-04-02
FI118675B (fi) 2008-02-15
ES2131318T3 (es) 1999-07-16
NO315544B1 (no) 2003-09-22
WO1995034291A1 (en) 1995-12-21
CA2192086A1 (en) 1995-12-21
FI965003A0 (fi) 1996-12-13
DE69508580D1 (en) 1999-04-29
FI965003L (fi) 1996-12-13
DE69508580T2 (de) 1999-09-23
NZ288185A (en) 1998-02-26
DK0765157T3 (da) 1999-10-25
AU2732795A (en) 1996-01-05
EP0765157B1 (en) 1999-03-24
HK1010335A1 (en) 1999-06-17
NO965381D0 (no) 1996-12-13
ATE177944T1 (de) 1999-04-15
CA2192086C (en) 2000-01-25
GR3030256T3 (en) 1999-08-31

Similar Documents

Publication Publication Date Title
DK0765157T3 (da) Pellets
ATE30380T1 (de) Pharmazeutische formulierungen mit mehrfachen einheiten.
NO175240C (no) Fremgangsmåte for fremstilling av et langsomt frigivende farmasöytisk preparat som omfatter sekundære granuler
CA2025703A1 (en) Pulsatile once-a-day delivery systems for minocycline
NO20011211D0 (no) Multippel enhet for kontrollert mateffektuavhengig frigivelse av farmasøytiske preparater og fremgangsmÕter for fremstilling av samme
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
EP1352895A3 (en) Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
ATE367802T1 (de) Verfahren zur sprühtrocknung von zusammensetzungen enthaltend fenofibrat
JPS63258406A (ja) 持続放出製剤
EP0388954A3 (en) Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions
ATE246505T1 (de) Zubereitung enthaltend cefaclor oder cephalexin mit modifizierter freisetzungsmatrix
ATE84032T1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
KR20110025833A (ko) 활성제의 일정한 (0-차) 방출을 위한 방출 시스템의 조성물 및 제조방법
MY124599A (en) Oral suspension of pharmaceutical substance
CY1108863T1 (el) Φαρμακευτικο σκευασμα εκτεταμενης απελευθερωσης ανεξαρτητης απο το ρη
IT8220758A1 (it) Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli
DE59305805D1 (de) Tilidin-dihydrogenorthophosphat, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen
EP0305968A3 (en) Compositions against protozoal diseases
WO2009006299A2 (en) Multi-particulate systems
DK1144420T3 (da) Sulfaterede phosphatidylinositoler, fremgangsmåde til fremstilling heraf og anvendelser heraf
EP0781135A4 (en) FORMULATIONS CONTAINING CODEINE
Park et al. Clinical trial of cefotaxime in patients with typhoid fever
JP4945869B2 (ja) 免疫賦活剤
ES2004693A6 (es) Un procedimiento para la preparacion de una composicion farmaceutica solida administrable por via oral, que contiene vinburnina como principio activo.
US20200289412A1 (en) Bioenhanced spirulina lozenge formulation

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees